Search results for "3S"
showing 10 items of 133 documents
"Table 5" of "Measurement of the differential cross-section for the production of an isolated photon with associated jet in p anti-p collisions at s*…
2008
Ratio of the differential cross section in the region ABS(YRAP(JET)) < 0.8 and YRAP(GAMMA)*YRAP(JET) < 0 to the region ABS(YRAP(JET)) < 0.8 and YRAP(GAMMA)*YRAP(JET) > 0.
"Table 10" of "Measurement of the differential cross-section for the production of an isolated photon with associated jet in p anti-p collisions at s…
2008
Ratio of the differential cross section in the region ABS(YRAP(JET)) < 0.8 and YRAP(GAMMA)*YRAP(JET) < 0 to the region ABS(YRAP(JET)) 1.5 TO 2.5 and YRAP(GAMMA)*YRAP(JET) < 0.
"Table 7" of "Measurement of the differential cross-section for the production of an isolated photon with associated jet in p anti-p collisions at s*…
2008
Ratio of the differential cross section in the region ABS(YRAP(JET)) < 0.8 and YRAP(GAMMA)*YRAP(JET) < 0 to the region ABS(YRAP(JET)) 1.5 TO 2.5 and YRAP(GAMMA)*YRAP(JET) > 0.
"Table 9" of "Measurement of the differential cross-section for the production of an isolated photon with associated jet in p anti-p collisions at s*…
2008
Ratio of the differential cross section in the region ABS(YRAP(JET)) < 0.8 and YRAP(GAMMA)*YRAP(JET) > 0 to the region ABS(YRAP(JET)) 1.5 TO 2.5 and YRAP(GAMMA)*YRAP(JET) < 0.
"Table 6" of "Measurement of the differential cross-section for the production of an isolated photon with associated jet in p anti-p collisions at s*…
2008
Ratio of the differential cross section in the region ABS(YRAP(JET)) < 0.8 and YRAP(GAMMA)*YRAP(JET) > 0 to the region ABS(YRAP(JET)) 1.5 TO 2.5 and YRAP(GAMMA)*YRAP(JET) > 0.
"Table 8" of "Measurement of the differential cross-section for the production of an isolated photon with associated jet in p anti-p collisions at s*…
2008
Ratio of the differential cross section in the region ABS(YRAP(JET)) 1.5 TO 2.5 and YRAP(GAMMA)*YRAP(JET) < 0 to the region ABS(YRAP(JET)) 1.5 TO 2.5 and YRAP(GAMMA)*YRAP(JET) > 0.
"Table 1" of "Antideuteron production in $\Upsilon(nS)$ decays and in $e^+e^- \to q\overline{q}$ at $\sqrt{s} \approx 10.58 \mathrm{\,Ge\kern -0.1em …
2014
The rate of antideuteron production from the decay of UPSILON(3S).
Influence of orthophosphate ions on the dissolution of tricalcium silicate
2008
International audience; Tricalcium silicate dissolution in the presence of orthophosphate ions was monitored by measuring the concentrations of calcium and silicate ions in dilute suspensions using a special dissolution cell coupled to an optical emission spectrometer. Results show that increasing adsorption of orthophosphate ions slows down the dissolution of Ca3SiO5 and that a calcium-phosphate precipitate may form at certain orthophosphate concentrations. These observations are correlated with results of calorimetric experiments carried out during the hydration of silica-rich cement pastes in the presence of the same salts.
Identification of Three Clinically Relevant Borrelia burgdorferi Sensu Lato Genospecies by PCR-Restriction Fragment Length Polymorphism Analysis of 1…
2004
ABSTRACT We report the results of a study of the prevalences of three clinically relevant Borrelia burgdorferi sensu lato genospecies ( Borrelia burgdorferi sensu stricto, Borrelia afzelii , and Borrelia garinii ) in 1,040 questing Ixodes ticks from all regions of Latvia, where Lyme borreliosis is endemic. The prevalences of Borrelia in Ixodes ricinus and Ixodes persulcatus were 22.6 and 27.9%, respectively. Molecular typing of B. burgdorferi from infected ticks was performed by restriction fragment length polymorphism (RFLP) analysis of PCR-amplified fragments of the 16S-23S ( rrs-rrlA ) rRNA intergenic spacer by using species-specific primers and subsequent sequencing. The dominant Borrel…
New potent antibacterials against Gram-positive multiresistant pathogens: effects of side chain modification and chirality in linezolid-like 1,2,4-ox…
2014
The effects of side chain modification and chirality in linezolid-like 1,2,4-oxadiazoles have been studied to design new potent antibacterials against Gram-positive multidrug-resistant pathogens. The adopted strategy involved a molecular modelling approach, the synthesis and biological evaluation of new designed compounds, enantiomers separation and absolute configuration assignment. Experimental determination of the antibacterial activity of the designed (S)-1-((3-(4-(3-methyl-1,2,4-oxadiazol-5- yl)phenyl)-oxazolidin-2-one-5-yl)methyl)-3-methylthiourea and (S)-1-((3-(3-fluoro-4-(3-methyl-1,2,4- oxadiazol-5-yl)phenyl)-oxazolidin-2-one-5-yl)methyl)-3-methylthiourea against multidrug resistan…